WX8 (Group A) will inhibit PIP2 biosynthesis only in PIKFYVE-sensitive cancer cells; Group A PIKFYVE inhibitors do not affect the viability of normal cells under conditions where they induce PIKYVE-dependent cell death. This evidence concerns the gene PIKFYVE and cancer.